RxDoctor Payments Data

Lindsey Johnson, MD

Family Medicine · Monroe, NCNPI 1710194907

Payments from drug & device makers

$206in general payments, 2019–2025

Across 11 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$101
  • Tactile Systems Technology Inc$26
  • Astellas Pharma US Inc$24
  • Fujifilm Healthcare Americas Corporation$22
  • Biogen$19
  • GSK$15

What the payments were for

  • Food & beverage$206100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$206 in reported general payments places this provider in the 40th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$237,751
Medicare patients
400
Services billed
5,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide219$257,699
MounjaroTirzepatide116$145,358
JardianceEmpagliflozin84$116,489
EliquisApixaban106$110,509
FarxigaDapagliflozin Propanediol62$63,420
LinzessLinaclotide55$48,545
XareltoRivaroxaban37$46,948
MyrbetriqMirabegron55$43,716
Tresiba Flextouch U-100Insulin Degludec53$28,868
RybelsusSemaglutide19$24,535
GemtesaVibegron19$24,321
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$21,046
TrulicityDulaglutide11$19,910
XifaxanRifaximin11$18,955
Breo ElliptaFluticasone/Vilanterol36$16,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$101$296,709249 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$15$54,35298 claims
Astellas Pharma US IncMyrbetriq$24$43,71655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Monroe

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →